JPRN-UMIN000022651已完成未知
Effects of ipragliflozin on nonalcoholic fatty liver disease in patients with type 2 diabetes - Effects of ipragliflozin on NAFLD in patients with type 2 diabetes
Ogawa Red Cross Hospital0 个研究点目标入组 60 人开始时间: 2016年6月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients who have history or current serious diabetic complication. 2. Patients that insulin dependence is suspected. 3. Patients who have history or current cardiac failure (New York Heart Association Class III or IV), myocardial infarction or cerebrovascular disorder. 4. Patients whose eGFR lower than 45 mL/min/1.73m2, serum creatinine higher than 1.5 mg/dL.
研究者
相似试验
已完成
不适用
ong-term effects of ipragliflozin on nonalcoholic fatty liver disease in patients with type 2 diabetesType 2 diabetes complicated by NAFLDJPRN-UMIN000040611Ogawa Red Cross Hospital66
招募中
不适用
The effect of treatment of non-alcoholic fatty liver with zucchini in pregnant women on the gestational Diabeteson-alcoholic Fatty Liver , Gestational Diabetes Mellitus.Fatty (change of) liver, not elsewhere classifiedK76.0IRCT20200419047137N1Arak University of Medical Sciences60
已完成
4 期
Effect of Empagliflozin on Liver Fat in Non-diabetic PatientsNon-alcoholic Fatty Liver DiseaseNCT04642261The University of Hong Kong98
已完成
4 期
Effects of Ipragliflozin on Excessive Fat in Type 2 Diabetes Patients With Non-alcoholic Fatty Liver Disease Treated With Metformin and PioglitazoneType 2 Diabetes With Non-alcoholic Fatty Liver (NAFLD)NCT02875821Yonsei University44
已完成
不适用
Effects of ipragliflozin on body composition and beta-cell function in Japanese patients with type 2 diabetesType 2 diabetesJPRN-UMIN000021623St. Marianna University School of Medicine20